FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical immunology and neurology, and can be used for immunological prediction of acute cerebral circulation disorders when determining immunological blood parameters. Amount of vascular endothelial growth factor (VEGF), interleukin (IL)-8 in blood serum, D-dimer in blood plasma is determined. If the combination of VEGF values greater than 550 pg/ml, IL-8 values greater than 14 pg/ml, D-dimer values greater than 245 ng/ml, the development of acute cerebral circulation disorders is predicted.
EFFECT: method enables minimally invasive, low-cost immunological prediction of acute cerebral circulation disorders, high specificity and sensitivity of determining three parameters by increasing specificity and sensitivity of determining three blood markers: VEGF, IL-8 and D-dimer.
1 cl, 4 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF IMMUNOLOGICAL PREDICTION OF SUDDEN CORONARY DEATH | 2023 |
|
RU2810015C1 |
| METHOD OF ACUTE CEREBRAL CIRCULATION DISORDER COURSE FORECAST | 2007 |
|
RU2327994C1 |
| COMPOSITION FOR NEUROPROTECTION AND STIMULATION OF BRAIN NEUROREGENERATION AFTER INJURY, AGENT BASED ON IT, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2803286C1 |
| METHOD FOR PREDICTING NEUROLOGICAL RECOVERY FROM THE 14TH TO THE 90TH DAYS OF ISCHEMIC STROKE OF THE BRAIN | 2021 |
|
RU2764355C1 |
| METHOD OF PREDICTING RECURRENT CEREBROVASCULAR COMPLICATIONS IN PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE IN ACUTE PERIOD OF ISCHEMIC STROKE | 2010 |
|
RU2425640C1 |
| METHOD OF TREATING ACUTE ISCHEMIC AND HEMORRHAGIC CEREBROVASCULAR DISEASE | 2010 |
|
RU2477637C2 |
| METHOD FOR PREDICTION OF RECURRENT HAEMORRHAGIC ACUTE CEREBRAL CIRCULATION DISORDER (HACCD) | 2015 |
|
RU2597990C1 |
| METHOD FOR PREDICTING ISCHEMIC INSULT CLINICAL BEHAVIOR | 2003 |
|
RU2236685C1 |
| METHOD OF DIFFERENTIALLY DIAGNOSING HEMORRHAGIC AND ISCHEMIC INSULT | 2001 |
|
RU2195671C2 |
| METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
